Potential conflict of interest: G.J.D. has received research support, is on the speaker's bureau, and is a member of an advisory board for Roche Pharmaceuticals. G.J.D. is also a consultant/advisor for Merck, Tibotec, and Abbott. J.G. is a member of an advisory board for Merck.
An expanding role for primary care providers in the treatment of hepatitis C virus infection in the community†
Version of Record online: 30 NOV 2011
Copyright © 2011 American Association for the Study of Liver Diseases
Volume 54, Issue 6, pages 2259–2261, December 2011
How to Cite
Grebely, J., Dore, G. J. (2011), An expanding role for primary care providers in the treatment of hepatitis C virus infection in the community. Hepatology, 54: 2259–2261. doi: 10.1002/hep.24649
The Kirby Institute for infection and immunity in society is funded by the Australian Government Department of Health and Ageing and is affiliated with the Faculty of Medicine, University of New South Wales. G.J.D. is supported by a National Health and Medical Research Council Practitioner Research Fellowship.
- Issue online: 30 NOV 2011
- Version of Record online: 30 NOV 2011
- Manuscript Accepted: 18 AUG 2011
- 1Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection. Am J Gastroenterol 2005; 100: 1772-1779., , , , , , et al.Direct Link:
- 6National Centre in HIV Epidemiology and Clinical Research (NCHECR). HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia. Annual surveillance report 2009. Sydney, Australia: National Centre in HIV Epidemiology and Clinical Research; 2009.